Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Lindgren, Gustaf ^a   Ekblad, Lars ^a   Vallon Christersson, Johan ^a   Kjellén, Elisabeth ^a   Gebre Medhin, Maria ^a   Wennerberg, Johan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Erythropoietin; Head and neck cancer; Surgery; Wound healing; Xenograft

Indexed keywords

CASPASE 3; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN; CASPASE; ERYTHROPOIETIN;

AIFM1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BCL2L13 GENE; BID GENE; BIK GENE; CANCER SURVIVAL; CARD10 GENE; CASP1 GENE; CELL CYCLE REGULATION; CONTROLLED STUDY; DIP GENE; DOWN REGULATION; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL INJURY; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; WOUND HEALING; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; ERYTHROPOIETIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION;

EID: 84907387754     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-648     Document Type: Article

References (27)

1. Ferlay J, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer 2008, 46:765-781.
2. Ferley J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:582-592.
3. Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, Portelance L, Crook J, Jones KD. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999, 86(8):1528-1536. 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E, 10526282.
4. Frommhold H, Guttenberger R, Henke M. The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 1998, 174(Suppl 4):31-34.
5. Silver DF, Piver MS. Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect. Gynecol Oncol 1999, 73(2):280-284. 10.1006/gyno.1999.5368, 10329047.
6. Glaser CM, Millesi W, Kornek GV, Lang S, Schull B, Watzinger F, Selzer E, Lavey RS. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 2001, 50(3):705-715. 10.1016/S0360-3016(01)01488-2, 11395239.
7. Wright JR, Ung YC, Julian JA, Pritchard KI, Whelan TJ, Smith C, Szechtman B, Roa W, Mulroy L, Rudinskas L, Gagnon B, Okawara GS, Levine MN. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 2007, 25(9):1027-1032. 10.1200/JCO.2006.07.1514, 17312332.
8. Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003, 362(9392):1255-1260. 10.1016/S0140-6736(03)14567-9, 14575968.
9. Leyland-Jones B, Semiglazov V, Pawlicki M, Pienkowski T, Tjulandin S, Manikhas G, Makhson A, Roth A, Dodwell D, Baselga J, Biakhov M, Valuckas K, Voznyi E, Liu X, . Vercammen Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005, 23(25):5960-5972. 10.1200/JCO.2005.06.150, 16087945, Vercammen.
10. Lai SY, Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 2005, 24(27):4442-4449. 10.1038/sj.onc.1208635, 15856028.
11. Mohyeldin A, Lu H, Dalgard C, Lai SY, Cohen N, Acs G, Verma A. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 2005, 7(5):537-543. 10.1593/neo.04685, 1501166, 15967106.
12. Abhold E, Rahimy E, Wang-Rodriguez J, Blair KJ, Yu MA, Brumund KT, Weisman RA, Ongkeko WM. Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro. BMC Res Notes 4:553.
13. Kjellen E, Sasaki Y, Kjellstrom J, Zackrisson B, Wennerberg J. Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma. Acta Otolaryngol 2006, 126(5):545-547. 10.1080/00016480500437427, 16698707.
14. Sasaki Y, Kjellen E, Mineta H, Wennerberg J, Ekblad L. No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo. Acta Oncol 2009, 48(7):1062-1069. 10.1080/02841860902913553, 19412811.
15. Henriksson E, Baldetorp B, Borg A, Kjellen E, Akervall J, Wennerberg J, Wahlberg P. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck. Acta Oncol 2006, 45(3):300-305. 10.1080/02841860600547380, 16644573.
16. Wennerberg J. Changes in growth pattern of human squamous-cell carcinomas of the head and neck during serial passages in nude mice. Int J Cancer 1984, 33(2):245-250. 10.1002/ijc.2910330213, 6693202.
17. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
18. da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13. 10.1093/nar/gkn923, 2615629, 19033363.
19. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4(10):R70. 10.1186/gb-2003-4-10-r70, 328459, 14519205.
20. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nuñez G, Fernandez-Luna JL. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999, 274(32):22165-22169. 10.1074/jbc.274.32.22165, 10428780.
21. Dolznig H, Habermann B, Stangl K, Deiner EM, Moriggl R, Beug H, Mullner EW. Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts. Curr Biol 2002, 12(13):1076-1085. 10.1016/S0960-9822(02)00930-2, 12121614.
22. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M. Erythropoietin Receptor-madiated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia. J Biol Chem 2001, 276:39469-39475. 10.1074/jbc.M105832200, 11504731.
23. Hardee ME, Rabbani ZN, Arcasoy MO, Kirkpatrick JP, Vujaskovic Z, Dewhirst MW, Blackwell KL. Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity. Mol Cancer Ther 2006, 5(2):356-361. 10.1158/1535-7163.MCT-05-0196, 16505109.
24. Ekblad L, Lindgren G, Persson E, Kjellen E, Wennerberg J. Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3. BMC Cancer 2013, 13(1):33. 10.1186/1471-2407-13-33, 3585883, 23351302.
25. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001, 264(1):169-184. 10.1006/excr.2000.5133, 11237532.
26. Haroon ZA, Amin K, Jiang X, Arcasoy MO. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 2003, 163(3):993-1000. 10.1016/S0002-9440(10)63459-1, 1868246, 12937140.
27. Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, Bauer K, Vasselli JR, Maranchie JK, Kohn KW, Buetow KH, Linehan WM, Weinstein JN, Lee MP, Klausner RD, Barrett JC. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res 2006, 66(14):7216-7224. 10.1158/0008-5472.CAN-06-0040, 16849569.